Revealing Three-Dimensional Printing Technology Advances for Oral Drug Delivery: Application to Central-Nervous-System-Related Diseases
<b>Background/Objectives.</b> Central nervous system (CNS)-related diseases such as Alzheimer’s and Parkinson’s, Attention Deficit Hyperactive Disorder (ADHD), stroke, epilepsy, and migraines are leading causes of morbidity and disability worldwide. New solutions for drug delivery are in...
Saved in:
| Main Authors: | Samir I. Paipa-Jabre-Cantu, Marisela Rodriguez-Salvador, Pedro F. Castillo-Valdez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/4/445 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting Neuroinflammation in Central Nervous System Diseases by Oral Delivery of Lipid Nanoparticles
by: Yuan Zou, et al.
Published: (2025-03-01) -
Oral microbiota and central nervous system diseases: A review
by: Xiaoxuan Zhang, et al.
Published: (2025-03-01) -
The Nasal–Brain Drug Delivery Route: Mechanisms and Applications to Central Nervous System Diseases
by: Yi Qiu, et al.
Published: (2025-06-01) -
Nanoplatform‐Enabled Genetic Interventions for Central Nervous System Disorders: Advances in Delivery Strategies and Therapeutic Potential
by: Fuming Liang, et al.
Published: (2025-06-01) -
Extracellular Vesicles Administered via Intrathecal Injection Mediate Safe Delivery of Nucleic Acids to the Central Nervous System for Gene Therapy
by: Brenda Wan Shing Lam, et al.
Published: (2025-07-01)